The present paper reviews the techniques allowing to assess sympathetic activity in humans, highlighting their advantages and limitations. While plasma noradrenaline measurement represents a useful and widely used method to evaluate sympathetic neural function, new approaches, developed starting from the seventies, like direct recording of sympathetic nerve traffic and noradrenaline spillover. These approaches have largely supplanted the plasma noradrenaline approach due to the precise estimation of the behavior of regional sympathetic neural function. The paper in particular will focus the microneurographic technique, considered as the gold standard, and on the new clinical evidences obtained with this technique.

Seravalle, G., Dimitriadis, K., Dell'Oro, R., Grassi, G. (2013). How to assess sympathetic nervous system activity in clinical practice. CURRENT CLINICAL PHARMACOLOGY, 8(3), 182-188 [10.2174/1574884711308030003].

How to assess sympathetic nervous system activity in clinical practice

DELL'ORO, RAFFAELLA;GRASSI, GUIDO
2013

Abstract

The present paper reviews the techniques allowing to assess sympathetic activity in humans, highlighting their advantages and limitations. While plasma noradrenaline measurement represents a useful and widely used method to evaluate sympathetic neural function, new approaches, developed starting from the seventies, like direct recording of sympathetic nerve traffic and noradrenaline spillover. These approaches have largely supplanted the plasma noradrenaline approach due to the precise estimation of the behavior of regional sympathetic neural function. The paper in particular will focus the microneurographic technique, considered as the gold standard, and on the new clinical evidences obtained with this technique.
Articolo in rivista - Review Essay
sympathetic nervous system; clinical practice
English
2013
8
3
182
188
none
Seravalle, G., Dimitriadis, K., Dell'Oro, R., Grassi, G. (2013). How to assess sympathetic nervous system activity in clinical practice. CURRENT CLINICAL PHARMACOLOGY, 8(3), 182-188 [10.2174/1574884711308030003].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/49687
Citazioni
  • Scopus 16
  • ???jsp.display-item.citation.isi??? ND
Social impact